[
  {
    "question": "A 58-year-old woman with HIV infection is brought to the emergency department because of a 2-week history of headaches, blurred vision, and confusion. Her current medications include antiretroviral therapy and trimethoprim-sulfamethoxazole. Neurological examination shows ataxia and memory impairment. Her CD4+ T-lymphocyte count is 90/\u03bcL. Analysis of her cerebrospinal fluid analysis shows lymphocytic predominant pleocytosis, and PCR is positive for Epstein-Barr virus DNA. An MRI of the brain with contrast shows a solitary, weakly ring-enhancing lesion with well-defined borders involving the corpus callosum. What is the most likely diagnosis?",
    "answer": "Based on the provided information, the most likely diagnosis is Progressive Multifocal Leukoencephalopathy (PML) secondary to JC virus reactivation, but given the presence of Epstein-Barr virus (EBV) DNA in the cerebrospinal fluid (CSF), and the patient's immunocompromised state, another possibility is Primary CNS Lymphoma (PCNSL) or possibly a Coinfection.\n\nHowever, the key findings here are the low CD4 count, the presence of a ring-enhancing lesion in the brain, and the lymphocytic predominant pleocytosis in the CSF. \n\nA more accurate diagnosis would be PCNSL, given the EBV DNA in the CSF, and a low CD4 count. PCNSL is more common in HIV patients with a CD4 count below 100 cells/\u03bcL, and it often presents with focal neurological symptoms and imaging findings like a solitary lesion in the brain.\n\nIt's essential to note that the definitive diagnosis would require a brain biopsy, but the combination of clinical presentation, imaging findings, and CSF analysis make PCNSL a strong consideration.",
    "true_answer": "The most likely diagnosis for a patient with HIV, presenting with neurological symptoms and a solitary ring-enhancing lesion, is primary cerebral lymphoma."
  },
  {
    "question": "A 25-year-old sexually active male presents to an internal medicine physician for a routine health check up after having several unprotected sexual encounters. After appropriate testing the physician discusses with the patient that he is HIV+ and must be started on anti-retroviral treatment. What medication prescribed acts on the gp41 subunit of the HIV envelope glycoprotein?",
    "answer": "The medication that acts on the gp41 subunit of the HIV envelope glycoprotein is Enfuvirtide (also known as T-20).",
    "true_answer": "The medication that targets the gp41 subunit of the HIV envelope glycoprotein is enfuvirtide."
  },
  {
    "question": "A 27-year-old man presents with a 2-week history of fever, malaise, and occasional diarrhea. On physical examination, the physician notes enlarged inguinal lymph nodes. An HIV-1 detection test is positive. Laboratory studies show a CD4+ count of 650/mm3. This patient is most likely currently in what stage of HIV infection?",
    "answer": "Based on the patient's CD4+ count of 650/mm^3, which is within the normal range, and the presence of symptoms such as fever, malaise, and enlarged inguinal lymph nodes, it is likely that the patient is in the acute or early acute retroviral syndrome stage of HIV infection, but more specifically, the acute retroviral syndrome typically occurs in the first few weeks after infection and usually resolves on its own.",
    "true_answer": "This patient is most likely currently in the stage of acute HIV infection."
  },
  {
    "question": "A 50-year-old male with HIV presents to his primary care provider complaining of persistent fevers and night sweats over the past four months. He has also experienced a productive cough. He has been poorly adherent to his HAART regimen. His past medical history also includes gout, hypertension, and diabetes mellitus. He takes allopurinol, enalapril, and metformin. His temperature is 100.9\u00b0F (38.3\u00b0C), blood pressure is 125/75 mmHg, pulse is 95/min, and respirations are 20/min. His CD4 count is 85 cell/mm^3 and a PPD is negative. A chest radiograph reveals cavitations in the left upper lobe and left lower lobe. Bronchoalveolar lavage reveals the presence of partially acid-fast gram-positive branching rods. A head CT is negative for any intracranial process. What is the mechanism of action of the most appropriate drug for managing this patient\u2019s condition?",
    "answer": "Based on the patient's symptoms and diagnostic findings, it appears that he has a case of pulmonary tuberculosis (TB) with cavitations, which is a common opportunistic infection in individuals with HIV/AIDS. The presence of partially acid-fast gram-positive branching rods is consistent with Mycobacterium tuberculosis.\n\nThe most appropriate drug for managing TB is Isoniazid (INH). The mechanism of action of Isoniazid is to inhibit the synthesis of mycolic acid, a critical component of the mycobacterial cell wall. Specifically, INH inhibits the enzyme enoyl-ACP reductase, which is essential for the synthesis of mycolic acid from fatty acids. This disrupts the cell wall of the bacteria, ultimately leading to their death.\n\nIt's worth noting that this patient's poor adherence to his HAART regimen may have contributed to his susceptibility to TB. A comprehensive treatment plan should include both antitubercular therapy and a renewed commitment to antiretroviral therapy to manage his HIV.",
    "true_answer": "The mechanism of action of the most appropriate drug to manage this patient's condition is inhibition of bacterial folic acid synthesis."
  },
  {
    "question": "A physician scientist is looking for a more efficient way to treat HIV. Patients infected with HIV mount a humoral immune response by producing antibodies against the HIV envelope proteins. These antibodies are the same antibodies detected by the ELISA and western blot assays used to diagnose the disease. The physician scientist is trying to generate a new, more potent antibody against the same HIV envelope proteins targeted by the natural humoral immune response. Of the following proteins, which is the most likely target of the antibody he is designing?",
    "answer": "Based on the information provided, the most likely target of the antibody the physician scientist is designing would be the gp120 protein. \n\nThe gp120 protein is a glycoprotein on the surface of the HIV envelope and is one of the primary targets of the humoral immune response. It plays a crucial role in the attachment and entry of the virus into host cells. The ELISA and Western blot assays often detect antibodies against gp120, gp41, and other envelope proteins, but gp120 is a key antigen for antibody-mediated neutralization.",
    "true_answer": "The most likely target of the antibody being designed for HIV envelope proteins is gp120."
  },
  {
    "question": "A 50-year-old HIV-positive male presents to the ER with a two-day history of fever and hemoptysis. Chest radiograph shows a fibrocavitary lesion in the right middle lobe. Biopsy of the afflicted area demonstrates septate hyphae that branch at acute angles. What is the most likely causal organism?",
    "answer": "Based on the clinical presentation and biopsy findings, the most likely causal organism is Pneumocystis jirovecii (formerly known as Pneumocystis carinii). However, the presence of septate hyphae that branch at acute angles suggests a different diagnosis. \n\nConsidering the branching pattern, I would lean towards Aspergillus species as a possible cause. Aspergillus is a common opportunistic pathogen in immunocompromised patients, and it can cause a range of pulmonary infections, including invasive aspergillosis, which can present with fibrocavitary lesions and hemoptysis.",
    "true_answer": "The most likely causal organism for the symptoms presented is Aspergillus fumigatus."
  },
  {
    "question": "A 43-year-old man with HIV infection comes to the physician because of a 2-week history of progressive diarrhea and a 3-kg (6.6-lb) weight loss. During this period, he has had 3\u20134 episodes of watery stools daily, with multiple instances of blood in the stool. He is currently receiving antiretroviral therapy with zidovudine, lamivudine, and dolutegravir. Physical examination shows pallor and dry mucous membranes. A colonoscopy shows multiple linear ulcers. Polymerase chain reaction of a stool sample is positive for cytomegalovirus. Treatment with valganciclovir is begun. Adding this drug to his current medication regimen puts this patient at greatest risk for what specific adverse effects?",
    "answer": "The patient is currently taking zidovudine, lamivudine, and dolutegravir. Adding valganciclovir, a medication used to treat cytomegalovirus (CMV) infections, may increase the risk of neutropenia due to its mechanism of action and potential interactions with other medications.\n\nValganciclovir is a prodrug of ganciclovir, which is a nucleoside analog that inhibits viral DNA synthesis. Zidovudine and lamivudine are also nucleoside analogs that inhibit HIV replication. The combination of these medications may increase the risk of bone marrow suppression, particularly neutropenia, due to overlapping mechanisms of action.\n\nNeutropenia is a condition characterized by a low white blood cell count, which can increase the risk of infections. Monitoring of the patient's white blood cell count will be essential when starting valganciclovir in this patient.",
    "true_answer": "Treatment with valganciclovir places the patient at increased risk for pancytopenia."
  },
  {
    "question": "A 28-year-old G1P0 woman at 16 weeks estimated gestational age presents for prenatal care. Routine prenatal screening tests are performed and reveal a positive HIV antibody test. The patient is extremely concerned about the possible transmission of HIV to her baby and wants to have the baby tested as soon as possible after delivery. Which of the following would be the most appropriate diagnostic test to address this patient\u2019s concern?",
    "answer": "For a newborn to be tested for HIV, the most appropriate diagnostic test would be the HIV DNA PCR (Polymerase Chain Reaction) test. This test detects the presence of HIV RNA in the baby's blood and is the recommended method for diagnosing HIV infection in infants born to HIV-positive mothers. It's typically performed at 14 to 21 days of age.",
    "true_answer": "The most appropriate test for early HIV diagnosis in a newborn is the polymerase chain reaction (PCR) for HIV RNA."
  },
  {
    "question": "A 32-year-old man comes to the office for a routine health maintenance examination. He admits to recently having an affair several months ago and requests STD testing. One week later, the results of a fourth-generation HIV antibody and antigen test return positive. The patient is counseled on the test result. The patient requests that his diagnosis not be disclosed to anyone, including his wife. The man's wife is also the physician's patient. What should be the most appropriate next step by the physician?",
    "answer": "The physician should inform the patient that, as a healthcare provider, they are bound by confidentiality laws, such as HIPAA in the US. However, they must also inform the patient that they cannot guarantee confidentiality if the patient poses a risk to himself or others. \n\nThe physician should explain that, due to the patient's recent exposure and positive test result, there is a risk of transmission to his wife. They should inform the patient that, under certain circumstances, they may be obligated to disclose this information to his wife, such as if she is at risk of exposure or if the patient's health is at risk due to non-disclosure. \n\nIt's also essential to inform the patient that disclosing the diagnosis to his wife could be a way to ensure his health and safety, as well as her health and safety, and that it's a decision that should be made in collaboration with the patient.",
    "true_answer": "The physician should report the HIV infection to the national health authorities while maintaining confidentiality per regulations."
  },
  {
    "question": "A 41-year-old woman presents with acute onset severe epigastric pain radiating to the back that began a few hours ago. She also complains of nausea and has vomited twice in the past hour. She denies any history of similar symptoms or trauma in the past. Past medical history is significant for diabetes type 2 and HIV infection diagnosed 6 months ago long-standing mild intermittent asthma, and generalized anxiety disorder. She takes metformin for her diabetes but does not remember the names of her HIV medications. She reports moderate social alcohol use. Her vital signs include temperature 37.6\u00b0C (99.6 \u00b0F), pulse 95/min, blood pressure 110/74 mm Hg, respiratory rate 12/min Her body mass index (BMI) is 21 kg/m2. Laboratory findings are significant for the following: Serum amylase: 415 U/L, Serum lipase: 520 U/L. A contrast CT of the abdomen reveals an edematous pancreas with peripancreatic fluid collection with a normal gallbladder. What is the most likely etiology of this patient\u2019s condition?",
    "answer": "Based on the patient's symptoms and laboratory findings, the most likely etiology of her condition is acute pancreatitis. The high serum amylase and lipase levels support this diagnosis. The CT scan showing an edematous pancreas with peripancreatic fluid collection further supports the diagnosis of pancreatitis.\n\nGiven her HIV status, it's essential to consider potential causes of pancreatitis that may be associated with HIV, such as:\n\n1. Antiretroviral therapy (ART) side effects: Certain ART medications can cause pancreatitis as a side effect. The patient's inability to remember her HIV medications makes it challenging to determine if she is on a medication that could be causing pancreatitis.\n2. Viral infections: HIV itself or co-infections like CMV or EBV may contribute to pancreatitis.\n3. Alcohol use: While she reports moderate social alcohol use, it's essential to consider the possibility of binge drinking or excessive alcohol consumption, which can contribute to pancreatitis.\n\nHowever, the normal gallbladder on the CT scan makes gallstones, a common cause of pancreatitis, less likely. Therefore, the patient's HIV status and potential ART side effects become more relevant factors to consider in the differential diagnosis.\n\nIt's crucial to further investigate the patient's HIV medications and their potential contribution to her pancreatitis.",
    "true_answer": "It is most likely related to their HIV medication."
  },
  {
    "question": " A 28-year-old primigravid woman at 38 weeks' gestation is brought to the emergency department in active labor. She has not had regular prenatal care. She has a history of HIV infection but is not currently on antiretroviral therapy. Her previous viral load is unknown. Treatment with intravenous zidovudine is begun to reduce perinatal transmission of the virus. What biological process is most likely disrupted by this drug\u2019s action mechanism?",
    "answer": "The drug zidovudine (AZT) is a nucleoside reverse transcriptase inhibitor (NRTI). Its mechanism of action involves the inhibition of the reverse transcriptase enzyme, which is essential for the replication of retroviruses, including HIV.\n\nThe reverse transcriptase enzyme is responsible for converting the viral RNA genome into a DNA copy, which is then integrated into the host cell's genome. By inhibiting this enzyme, zidovudine prevents the viral replication and transcription process.\n\nTherefore, the biological process most likely disrupted by zidovudine's action mechanism is the reverse transcription of viral RNA into DNA.",
    "true_answer": " Zidovudine affects elongation of viral DNA by inhibiting the viral reverse transcriptase enzyme."
  },
  {
    "question": "What is known about DNA methylation profiles in patients with latent HIV-1 or with an active infection?",
    "answer": "DNA methylation is an epigenetic mechanism that can influence gene expression. In the context of HIV-1 infection, research has shown that DNA methylation patterns can differ between individuals with latent HIV-1 infection and those with active infection.\n\n Studies have found that:\n\n1.  Latent HIV-1 infection is associated with global DNA hypomethylation in the host genome. This means that the overall methylation levels are lower in individuals with latent HIV-1 compared to those without the virus.\n2.  Specific gene promoter regions involved in immune response and inflammation are hypermethylated in latent HIV-1 infection, which may contribute to the virus's ability to evade the immune system.\n3.  In contrast, active HIV-1 infection is associated with increased DNA methylation in certain regions, which may be related to the virus's ability to replicate and evade immune responses.\n4.  Some research suggests that changes in DNA methylation patterns may be associated with the development of HIV-associated neurocognitive disorders (HAND) and other comorbidities in individuals with HIV.\n\nIt's essential to note that these findings are based on observational studies and more research is needed to fully understand the relationship between DNA methylation and HIV-1 infection.",
    "true_answer": "DNA methylation is correlated with and functionally linked to HIV-1 pathogenesis and latency. In active infection, HIV-1 infection is associated with global changes in host cell DNA methylation patterns, while in latent infection, methylation of the proviral DNA, particularly in the 5\u2019 LTR promoter and intragenic regions, plays a crucial role in maintaining viral latency."
  }
]